Why is Aarey Drugs falling/rising?

As of 22-Jul, Aarey Drugs & Pharmaceuticals Ltd is experiencing a price increase, currently at 66.50, which reflects a change of 1.23 or 1.88% upward. The stock has shown strong performance over the past month with a return of 17.45%, significantly outperforming the Sensex, which has seen a decline of 0.27%. Today's trading has been characterized by high volatility, with an intraday volatility of 6000.92%, and a notable increase in delivery volume by 50.11% compared to the 5-day average. Despite the stock's attractive valuation and its ability to outperform the BSE500 over various time frames, it is important to note that the company has faced challenges, including a significant drop in profits and operating losses.
In the broader market context, Aarey Drugs has outperformed the benchmark in both the short and long term, with a year-to-date return of 17.26% compared to the Sensex's 5.18%. This strong performance may be attracting investor interest, contributing to the stock's upward movement. However, the company’s weak long-term fundamental strength, highlighted by a poor EBIT to Interest ratio and declining sales, suggests caution for potential investors. While the stock is trading at a discount compared to its peers, the overall financial health of the company raises concerns that could impact future performance.